ADDEX THERAPEUTICS LTD

Analyst Reco. Addex Therapeutics Ltd

Equities

ADXN

CH0029850754

Market Closed - Swiss Exchange Other stock markets 09:01:30 26/04/2024 pm IST			5-day change	1st Jan Change
0.1155 ^CHF	+0.43%		-23.26%	+151.09%

24/04	Top Premarket Decliners	MT
18/04	Transcript : Addex Therapeutics Ltd, 2023 Earnings Call, Apr 18, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy	23/22/23	MT
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate	17/22/17	DJ
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate	17/22/17	CI
HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Rating	31/22/31	MT
HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy Rating	11/22/11	MT
ADDEX THERAPEUTICS : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Price Target	21/21/21	MT
Addex Therapeutics : Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM	02/18/02	GL
Addex Therapeutics : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics	08/16/08	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer